The role of IL1-β gene polymorphism (rs1146327) in non-small cell lung cancer

The goal of this written research is to study the role of IL1-β gene SNP rs1146327 in non-small cell lung cancer (NSCLC). Although the etiology and compulsive mechanisms of NSCLC are unknown, and it is a multifaceted and complex illness, age and inherited factors are supposed to have a part in its growth. Nonetheless, smoking, age, family history, and genetic variables are the most commonly cited factors related with NSCLC. We tested the rs1146327 polymorphism in patients with NSCLC and comparison groups using real-time PCR, and found no statistically big differences in findings between the two groups of affected and control groups. Our data show that the patients' dominant form (GG), heterozygote (GA), and recessive form (AA) rates are 33.3 percent, 43.8 percent, and 22.9 percent, respectively. However, the dominant form (GG), heterozygote (GA), and recessive form (AA) percentages in the comparative group are 16.7 percent, 59.5 percent, and 23.8 percent, respectively. According to our findings, the homozygote mutant type (AA) ratio was larger in controls than in affected persons, despite the change was not significant (p-value = 0.091). The homozygote wild type (GG) ratio was also greater in controls than in patients, with a p-value of 0.951, which was not major.